Cargando…
Preclinical investigation of the pharmacokinetics, metabolism, and protein and red blood cell binding of DRDE-07: a prophylactic agent against sulphur mustard
DRDE-07, a newly synthesized amifostine analog currently under clinical investigation in a phase I trial, is a potent antidote against sulfur mustard toxicity. The purpose of this research was to evaluate the pharmacokinetic profile of DRDE-07 in female Swiss Albino mice after a single oral dose of...
Autores principales: | Verma, Pankaj, Vijayaraghavan, Rajagopalan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4629098/ https://www.ncbi.nlm.nih.gov/pubmed/26579409 http://dx.doi.org/10.1016/j.apsb.2014.08.002 |
Ejemplares similares
-
Analgesic and anti-inflammatory activity of amifostine, DRDE-07, and their analogs, in mice
por: Bhutia, Yangchen Doma, et al.
Publicado: (2010) -
Remobilization and fate of sulphur in mustard
por: Borpatragohain, Priyakshee, et al.
Publicado: (2019) -
Comparative evaluation of some flavonoids and tocopherol acetate against the systemic toxicity induced by sulphur mustard
por: Vijayaraghavan, R., et al.
Publicado: (2008) -
Amifostine Analog, DRDE-30, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice
por: Arora, Aastha, et al.
Publicado: (2018) -
N-Acetylcysteine as a treatment for sulphur mustard poisoning
por: Sawyer, Thomas W.
Publicado: (2020)